Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial
D Ruttens, S E Verleden, E Vandermeulen, H Bellon, B M Vanaudenaerde, J Somers, A Schoonis, V Schaevers, D E Van Raemdonck, A Neyrinck, L J Dupont, J Yserbyt, G M Verleden, R Vos, D Ruttens, S E Verleden, E Vandermeulen, H Bellon, B M Vanaudenaerde, J Somers, A Schoonis, V Schaevers, D E Van Raemdonck, A Neyrinck, L J Dupont, J Yserbyt, G M Verleden, R Vos
Abstract
Prophylactic azithromycin treatment has been demonstrated to improve freedom from bronchiolitis obliterans syndrome (BOS) 2 years after lung transplantation (LTx). In the current study, we re-evaluated the long-term effects of this prophylactic approach in view of the updated classification system for chronic lung allograft dysfunction (CLAD). A retrospective, intention-to-treat analysis of a randomized controlled trial comparing prophylactic treatment with placebo (n = 43) versus azithromycin (n = 40) after LTx was performed. Graft dysfunction (CLAD), graft loss (retransplantation, mortality), evolution of pulmonary function and functional exercise capacity were analyzed 7 years after inclusion of the last study subject. Following LTx, 22/43 (51%) patients of the placebo group and 11/40 (28%) patients of the azithromycin group ever developed CLAD (p = 0.043). CLAD-free survival was significantly longer in the azithromycin group (p = 0.024). No difference was present in proportion of obstructive versus restrictive CLAD between both groups. Graft loss was similar in both groups: 23/43 (53%) versus 16/40 (40%) patients (p = 0.27). Long-term pulmonary function and functional exercise capacity were significantly better in the azithromycin group (p < 0.05). Prophylactic azithromycin therapy reduces long-term CLAD prevalence and improves CLAD-free survival, pulmonary function, and functional exercise capacity after LTx.
Trial registration: ClinicalTrials.gov NCT01009619.
Keywords: (allograft) function/dysfunction; bronchiolitis obliterans (BOS); clinical research/practice; lung; lung failure/injury; lung transplantation/pulmonology; preventive healthcare; rejection: chronic.
© Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.
Source: PubMed